|
Q4 2021
Filed on Feb 02, 2022
|
29,366
|
$19.94 - $26.96
$586K - $792K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
10,597
|
$17.37 - $19.39
$184K - $205K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
57,054
|
N/A
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
133,399
|
$3.06 - $5.25
$408K - $700K
|
|
Pimco Income Opportunity Fd
|
Q4 2021
Filed on Feb 02, 2022
|
127,597
|
N/A
|
|
Invesco Exch Trd Slf Idx Fd
|
Q4 2021
Filed on Feb 02, 2022
|
17,522
|
N/A
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
13,277
|
$7.65 - $8.57
$102K - $114K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
5,389
|
$40.93 - $54.57
$221K - $294K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
6,773
|
$301.06 - $339.69
$2.04M - $2.3M
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
89,943
|
$28.49 - $32.6
$2.56M - $2.93M
|
|
Invesco Exch Trd Slf Idx Fd
|
Q4 2021
Filed on Feb 02, 2022
|
20,741
|
N/A
|
|
Nuveen Tax Advantaged Divid
|
Q4 2021
Filed on Feb 02, 2022
|
21,335
|
N/A
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
788
|
$411.52 - $452.34
$324K - $356K
|
|
Enable Midstream Partners LP
|
Q4 2021
Filed on Feb 02, 2022
|
62,338
|
N/A
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
10,700
|
$10.1 - $15.12
$108K - $162K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
69,864
|
$27.03 - $29.82
$1.89M - $2.08M
|
|
Nuveen Diversified Divid & I
|
Q4 2021
Filed on Feb 02, 2022
|
37,598
|
N/A
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
13,502
|
N/A
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
10,907
|
$12.01 - $15.91
$131K - $174K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
1,925
|
$113.67 - $134.45
$219K - $259K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
3,210
|
$51.76 - $79.62
$166K - $256K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
9,718
|
$26.04 - $26.17
$253K - $254K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
11,000
|
$16.42 - $19.86
$181K - $218K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
8,948
|
$17.79 - $28.92
$159K - $259K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
8,955
|
$17.49 - $44.3
$157K - $397K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
3,975
|
$76.51 - $93.96
$304K - $373K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
2,625
|
$34.56 - $96.6
$90.7K - $254K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
16,711
|
$17.94 - $41.15
$300K - $688K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
2,555
|
$52.38 - $105.72
$134K - $270K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
2,489
|
$64.2 - $142.68
$160K - $355K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
23,007
|
$12.45 - $20.56
$286K - $473K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
19,300
|
$1.09 - $2.55
$21K - $49.2K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
10,444
|
$47.53 - $56.52
$496K - $590K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
5,166
|
$34.32 - $44.45
$177K - $230K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
8,118
|
$25.24 - $26.03
$205K - $211K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
14,845
|
$33.83 - $40.0
$502K - $594K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
12,340
|
$15.16 - $18.83
$187K - $232K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
10,700
|
$4.6 - $6.88
$49.2K - $73.6K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
61,900
|
N/A
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
9,740
|
$17.48 - $26.65
$170K - $260K
|
|
Dicerna Pharmaceuticals Inc
|
Q4 2021
Filed on Feb 02, 2022
|
14,016
|
N/A
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
11,241
|
$25.65 - $31.66
$288K - $356K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
10,057
|
$3.04 - $6.01
$30.6K - $60.4K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
21,120
|
$40.32 - $47.28
$852K - $999K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
7,300
|
$26.4 - $29.99
$193K - $219K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
12,200
|
$0.9 - $1.76
$11K - $21.5K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
6,182
|
$75.2 - $88.55
$465K - $547K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
14,500
|
$1.77 - $3.87
$25.7K - $56.1K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
10,500
|
$3.16 - $6.44
$33.2K - $67.6K
|
|
|
Q4 2021
Filed on Feb 02, 2022
|
9,990
|
$46.99 - $59.46
$469K - $594K
|
|